Locations:
Search IconSearch
September 19, 2016/Cancer/News & Insight

ASTRO 2016 – Tuesday, September 27

Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASTRO Annual Meeting

21016-CCCC-ASCO_650x450

Oral Presentations

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

2:00 p.m.

Presenter: Kailin Yang, PhD
Co-Authors: Wang X, Xie Q, Kim LJY, Flavahan WA, Chao ST, Rich JN

Radiosensitization of Glioblastoma Stem Cells through Targeting Metabolic Reprogramming

257 A/B

4:45 p.m.

Presenter: Shree Agrawal, BS

Co-Author: Stephenson AJ, Michalski J, Efstathiou J, Pisansky TM, Feng F, Hamstra D, Koontz B, Liauw S, Abramowitz M, Pollack A, Anscher M, Moghanaki D, Den R, Stephans KL, Gao T, Kattan M, Tendulkar RD

Prostate Cancer Specific Mortality and Survival Outcomes for Salvage Radiation Therapy after Radical Prostatectomy

258 A/B/C

5:05 p.m.

Co-Authors: Ramey SJ, Abramowitz MC, Moghanaki D, Agrawal S, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Anscher MS, Pollack A, Den RB, Stephans KL, Kattan MW, Gao T, Stephenson AJ, Tendulkar RD

Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Post-Prostatectomy Salvage Radiotherapy

258 A/B/C

Poster Presentations
Poster Viewing Time
Hall C

10:00 a.m. – 5:00 p.m.

Re-irradiation Outcomes After Upfront Larynx Preservation or Total Laryngectomy: A Multi-institutional Analysis
Authors: Awan MJ, Zakem SJ, Ward MC, Machtay M, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Dault J, Higgins KA, Beitler JJ, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Heron DE, Yao M

Clinical and Quality of Life Implications of Vertebral Compression Fracture following Spine Radiosurgery
Authors: Balagamwala EH, Miller JA, Angelov L, Suh JH, Mohammadi AM, Djemil T, Magnelli A, Soeder S, Chao ST

Advertisement

A comparison of oncologic and toxicity outcomes in patients receiving conventional external beam radiotherapy versus SBRT to instrumented spinal fields
Authors: Berriochoa C, Bennett E, Miller JA, Balagamwala EH, Ward MC, Chao S, Suh JH, Benzel E, Soeder S, Yu N, Manyam B, Angelov L

Episcleral brachytherapy for ocular hemangioma: indications and outcomes
Authors: Berriochoa C, Suh JH, Wilkinson A, Singh AD

Effects of Machine and Collimator Dose Rates on Pain Control and Facial Numbness in Stereotactic Radiosurgery for Trigeminal Neuralgia
Authors: Chaung K, Kotecha R, Modugula S, Barnett GH, Murphy ES, Reddy CA, Suh JH, Neyman G, Machado A, Nagel S, Chao ST

Clinical Outcomes Following Breast Conserving Therapy versus Mastectomy for T1-2N0 Triple-Negative Breast Cancer
Authors: Dai C, Miller JA, Shah CS, Tendulkar RD

Sparing level IB in node positive, HPV associated oropharyngeal carcinoma: an early safety and efficacy analysis
Authors: Joshi NP, Juloori A, Ward MC, Qu Hai, Greskovich JG, Murray E, Potter J, Dorfmeyer A, Xia P, Koyfman SA

Selectively sparing the submandibular gland when level IB lymph nodes are included in the radiation target volume: a safety and toxicity analysis in cancers of the oropharynx and oral cavity
Authors: Juloori A, Joshi NP, Ward MC, Xia P, Koyfman SA, Greskovich JF

Managing Local Recurrence After Primary Resection of Non-Small Cell Lung Cancer: The Role for Salvage SBRT
Authors: Juloori A, Vassil A, Woody N, Stephans K, Videtic G.

Advertisement

Consensus Statement from the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma – Patient Selection and Pre- and Post-SBRT Evaluation
Authors: Karam I, Yao M, Heron D, Poon I, Koyfman S, Yom S, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo J, Lee V, Foote R, Harter K, Lee N, Sahgal A, Lo S

Consensus Statement from the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma – Technical Factors
Authors: Karam I, Yao M, Heron D, Poon I, Koyfman S, Yom S, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo J, Lee V, Foote R, Harter K, Lee N, Sahgal A, Lo S

Treatment and Prognosis in Adult Patients with Spinal Ependymoma
Authors: Kim LJY, Yang K, Suh JH, Murphy ES, Chao ST

After transoral resection for early stage, HPV-positive base of tongue cancer, could omitting the primary bed be worth the risk? A dosimetric analysis
Authors: Kittel JA, Ward MC, Cui T, Murray E, Joshi N, Koyfman S, Xia P

The role of adjuvant radiation therapy in patients with myxopapillary ependymomas
Authors: Kotecha R, Modugula S, Angelov L, Benzel E, Reddy CA, Prayson R, Kalfas I, Schlenk R, Krishnaney A, Steinmetz MP, Bingaman W, Suh JH, Chao ST

Changing Trends in Brain Metastasis: A 20 Year Review of Patient Outcomes
Authors: Kotecha R, Suh JH, Barnett GH, Murphy ED, Ahluwalia MS, Reddy CA, Parsons M, Vogelbaum MA, Angelov L, Mohammadi AM, Stevens GHJ, Peereboom DM, Chao ST

A Prospective Analysis of Quality of Life Outcomes following Stereotactic Radiosurgery for Trigeminal Neuralgia
Authors: Kotecha R, Miller JA, Modugula S, Barnett GH, Murphy ES, Reddy CA, Suh JH, Neyman G, Machado A, Nagel S, Chao ST

Advertisement

Dramatic Reduction in the Need for Feeding Tube Use in HPV + Oropharyngeal Cancer in the IMRT Era
Authors: Koyfman SA, Ward MC, Houston N, Joshi N, Harr BA, Bodmann J, Ives DI, Rahe M, Nwizu TI, Adelstein DA, Greskovich JF

Institutional Experience of High Risk Low Grade Glioma in the Temozolomide Era
Authors: Leyrer CM, Murphy ES, Suh JH, Vogelbaum MA, G. Stevens HJ, Peereboom D, Chao ST, Barnett GH, Mohammadi AM, Yu JS, Ahluwalia MS

Trial Sponsorship and Self-Reported Conflicts of Interest in Clinical Trials of Central Nervous System Malignancies
Authors: Mendez L, Moraes F, Suh JH, Taunk N, Souhami L, Slotman B, Weltman E, Marta G

Healthcare Expenditures Associated with the Management of Multiple Brain Metastases. Poster presentation
Authors: Miller JA, Kotecha R, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Ahluwalia MS, Chao STC

Quality of Life following Stereotactic Radiosurgery for Single and Multiple Brain Metastases
Authors: Miller JA, Kotecha R, Barnett GH, Suh JH, Angelov L, Murphy ES, Vogelbaum MA, Mohammadi AM, Ahluwalia MS, Chao STC

The Impact of Dose Escalation upon Cost Reduction following Stereotactic Radiosurgery for Trigeminal Neuralgia
Authors: Miller JA, Kotecha R, Modugula S, Barnett GH, Murphy ES, Reddy CA, Suh JH, Neyman G, Machado A, Nagel S, Chao ST
The Impact of Receptor Status on Local Control of Breast Metastases following Spine Stereotactic Radiosurgery
Authors: Miller JA, Balagamwala EH, Angelov L, Suh JH, Yang K, Tariq MB, Magnelli A, Soeder S, Mohammadi AM, Djemil T, Chao ST

Spine Stereotactic Radiosurgery with Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
Authors: Miller JA, Balagamwala EH, Angelov L, Suh JH, Rini B, Garcia J, Ahluwalia M, Chao, ST

Advertisement

Quality of Life Outcomes following Spine Stereotactic Radiosurgery
Authors: Miller JA, Balagamwala EH, Angelov L, Suh JH, Tariq MB, Yang K, Magnelli A, Mohammadi AM, Djemil T, Chao ST

Vertebral Body Height Loss following Spine Stereotactic Radiosurgery for Renal Cell Carcinoma Metastases
Authors: Miller JA, Balagamwala EH, Angelov L, Suh JH, Magnelli A, Mohammadi AM, Djemil T, Chao ST

Impact of Radiosurgery Dose for Brain Metastasis less than or equal to 2 cm in Size
Authors: Mohammadi AM, Murphy ES, Schroeder JL, Elson P, Angelov L, Weil RJ, Chao ST, Yu JS, Suh JH, Barnett GH, Vogelbaum MA

Improving Access to Cancer Care: Watermelon as a QA Phantom for Cranial SRS Treatments
Authors: Parsai, S, Salehi N

Predictors of Receipt of Regional Nodal Irradiation in Patients with Pathologic Complete Response in the Axilla to Neoadjuvant Chemotherapy
Authors: Pham YD, Grover S, Badiyan S, Trifiletti D, Showalter S, Juloori A, Freedman G, Tendulkar RD, Nichols E, Feigenberg S, Shah CS

Postmastectomy radiation therapy reduces locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes: 8-year results
Authors: Pham YD, Rehman S, Reddy CA, Shukla ME, Moore H, Budd GT, Crowe JP, Shah C, Cherian S, Tendulkar RD

Long Term Toxicity Comparison between Brachytherapy and Radical Prostatectomy in High Risk Prostate Cancer
Authors: Weller MA, Reddy CA, Klein EA, Ulchaker J, Angermeier K, Campbell S, Stephenson A, Tendulkar R, Stephans K, Ciezki JP

A biological basis for local failure after lung stereotactic body radiation therapy
Authors: Woody NM, Stephans KL, Andrews M, Zhuang T, Reddy CA, Xia P, Videtic GMM, Abazeed ME

Treatment Outcomes of Adult Primary Spinal Cord Lymphoma: A Population-based Study
Authors: Yang K, Kim L, Suh JH, Murphy ES, Chao ST

Spine Stereotactic Body Radiation Therapy for Palliative Management of Metastatic Lung Cancer
Authors: Yang K, Miller JA, Balagamwala EH, Angelov L, Suh JH, Magnelli A, Soeder S, Mohammadi AM, Djemil T, Chao ST

Reduction of Couch Position Overrides during External Beam Radiotherapy
Authors: Yu N, Meier T, Packanik T, Barrett P, Chao ST, Xia P, Suh JS

Exploring the impact of “time-to-treatment” in early stage medically inoperable lung cancer patients referred for lung SBRT
Authors: Videtic GMM, Woody NM, Stephans KL

Heterogeneous Dose-Escalated Prostate SBRT for All Risk Prostate Cancer: An Institutional Phase II Study
Authors: Stephans K, Thousand R, Reddy C, Magnelli A, Zhuang T, Qi P, Keller L, Blair H, Kotecha R, Mastroianni A, Berglund R, Stovsky M, Klein E, Tendulkar RD

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad